Thoracic Oncological Emergencies - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

Thoracic Oncological Emergencies

Description:

External beam radiotherapy/Brachytherapy. Specific therapy-endobronchial. Mechanical debulking ... Brachytherapy. External beam radiotherapy. Surgical ... – PowerPoint PPT presentation

Number of Views:190
Avg rating:3.0/5.0
Slides: 24
Provided by: chris520
Category:

less

Transcript and Presenter's Notes

Title: Thoracic Oncological Emergencies


1
Thoracic Oncological Emergencies
  • Carrie Featherstone
  • Consultant Clinical Oncologist
  • Beatson West of Scotland Cancer Centre

2
Thoracic Oncological Emergencies
  • Airway
  • Tracheal occlusion (extrinsic and intrinsic)
  • Breathing
  • Haemoptysis
  • Breathlessness
  • Effusions
  • Circulation
  • SVCO
  • Pericardial effusions

3
Thoracic Oncological Emergencies
  • Acute
  • Oxygen
  • Airway
  • Nebulised Saline/ B-agonists/Adrenaline
  • Intravenous steroids
  • Diuretics
  • BiPAP
  • ??Heliox

4
Thoracic Oncological Emergencies
  • Acute
  • Oxygen
  • Airway
  • Nebulised Saline/ B-agonists/Adrenaline
  • Intravenous steroids
  • Diuretics
  • BiPAP
  • ??Heliox
  • NOT STANDARD ASTHMA/COPD
  • What now and who

5
Who now?
6
cardiologist
anaesthetist
Cardiothoracic surgeon
radiology
otolaryngology
oncologist
respiratory
7
Airway assessment
  • Level of obstruction
  • Oral cavity
  • Above or below vocal cords
  • Tracheal
  • Degree of Obstruction
  • Presumably subtotal
  • Hopefully secretions/oedema

8
Intrinsic and Extrinsic Compression
Bronchoscopic assessment can be therapeutic and
diagnostic
9
Extrinsic compression/Intrinsic obstruction
  • Extrinsic
  • Head and neck cancer
  • Thyroid Cancer
  • Lung cancer-Small cell or non-small cell
  • Lymphoma
  • Thymoma (myasthenia)
  • Intrinsic
  • Tracheal
  • adenoid cystic
  • non-small cell lung cancer

10
Specific therapies
  • Bronchoscopic
  • Surgery
  • Chemotherapy
  • External beam radiotherapy/Brachytherapy

11
Specific therapy-endobronchial
  • Mechanical debulking
  • Laser
  • Electrocautery
  • Argon
  • PDT
  • (diagnostic tissue/ebus)
  • Mostly fast and effective
  • complications

12
Specific Therapy-stent
13
Specific therapy-Surgery
  • Very few but important as maybe curative
  • Diagnostic

14
Specific therapy-Chemotherapy/radiotherapy
  • Lymphoma
  • Small cell lung cancer
  • Non small cell
  • Can be given in ITU
  • Can respond quickly but dependent on histology
  • Different prognosis

15
Central airways obstruction
Acute management/diagnosis
Dilation/coring Laser photoresection Electrocauter
y Argon plasma coagulation Photodynamic Brachyther
apy External beam radiotherapy
Dilation Stent Brachytherapy External beam
radiotherapy
16
Breathing
  • Haemoptysis
  • Tranexamic Acid
  • Laser
  • Radiotherapy
  • Effusion
  • Aspirate
  • Pleurodesis
  • Breathlessness
  • Oxygen
  • Nebs
  • Steroids
  • Morphine/Oxycodone
  • Anaemia
  • Radiotherapy/Chemotherapy

17
Circulation
Superior vena caval obstruction
Pericardial effusions
18
Superior vena caval obstruction
  • Compression of the superior vena cava (SVC) by
    either a tumour arising in the right main or
    upper lobe bronchus or mediastinal
    lymphadenopathy (usually right paratracheal or
    precarinal).
  • Malignancy is the commonest cause (gt90)
  • Other causes include thrombus, iv catheters, ext
    compression (ruptured thoracic aneurysm and
    trauma)
  • Dexamethasone
  • Anticoagulate
  • Stent
  • Anticancer therapy

19
Results of systematic review
  • C/RT (n777)
  • mean age 56-66 (29-88)
  • QoL none
  • RR 60-77
  • Rapidity of response
  • 7, 10 or 15 days
  • Median 14 days
  • 75 by 3 weeks
  • Stent (n159)
  • Mean age 58-72 (37-85)
  • Not split by tumour type
  • RR 95 (84-100)
  • Rapidity of response
  • facial oedema 24 hours
  • Arm oedema 72 hours

20
Results of systematic review
  • C/RT
  • Relapse
  • SCLC(73 of cases)
  • recurrence in 16.7
  • NSCLC (20 of cases) recurence in 18.5
  • Relapse 1-16 months after initial Rx
  • Median survival 2-9.5 months
  • Stent
  • Relapse due to thrombus or tumour ingrowth
  • Relapse 10.7
  • Relapse median 1-2 months range 3 days to 8
    months
  • Median survival 1.5-6.5 months

21
Implications for practice
  • Need anti-cancer treatment in both SCLC and NSCLC
    to maximise survival, to improve maintain QoL
  • SCLC and lymphoma
  • stent on relapse
  • or if SVCO persists following initial
    treatment)
  • NSCLC/other
  • stent on initial presentation on
    relapse/persistence

22
Pericardial Effusion
  • Pericardiocentesis
  • Pericardial Window
  • Intrapericardial sclerosant/chemo
  • Systemic therapy

23
cardiologist
anaesthetist
Cardiothoracic surgeon
radiology
otolaryngology
oncologist
respiratory
Write a Comment
User Comments (0)
About PowerShow.com